Pfizer opens global drug development centre in Chennai
The centre will develop small molecules, innovative formulations and APIs for global markets
Stay updated with breaking news from Engineering Gte Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The centre will develop small molecules, innovative formulations and APIs for global markets
American Pharma giant Pfizer has operationalized its largest and only drug development centre in Asia in the Indian city of Chennai. Set up at a cost of USD20 million (approx INR150 crore), the facility will carry out the development of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) for a wide range of Prizer's offerings. While API refers to the component of the drug that causes the intended effect, FDF refers to the finished drug that is meant for consumption.
In a significant move to bring critical research and development capabilities under one roof, pharmaceutical company Pfizer has set up a global drug development centre at the IIT Madras Research Park in Tamil Nadu's Chennai.
Chennai : In a significant move to bring critical research and development (R&D) capabilities under one roof, Pfizer has set up a global drug development center at the IIT Madras Research Park in Chennai, India. The center’s capabilities will inc
The centre will develop small molecules, innovative formulations and APIs for global markets